Free Trial

Karen Marie Rapp Sells 500 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus logo with Computer and Technology background

Plexus Corp. (NASDAQ:PLXS - Get Free Report) Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $130.77, for a total value of $65,385.00. Following the completion of the sale, the director now directly owns 9,365 shares in the company, valued at $1,224,661.05. This represents a 5.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Plexus Stock Up 0.3%

PLXS traded up $0.42 on Thursday, hitting $132.30. 33,423 shares of the company were exchanged, compared to its average volume of 177,486. The firm has a 50-day moving average price of $125.94 and a two-hundred day moving average price of $140.88. The company has a market cap of $3.58 billion, a price-to-earnings ratio of 30.70 and a beta of 0.80. Plexus Corp. has a twelve month low of $100.96 and a twelve month high of $172.89. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.12. The business had revenue of $980.17 million during the quarter, compared to analysts' expectations of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The business's quarterly revenue was up 1.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.94 EPS. On average, equities analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on PLXS. Stifel Nicolaus set a $145.00 price target on Plexus in a research note on Thursday, April 24th. Needham & Company LLC reiterated a "buy" rating and set a $162.00 price objective (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Finally, Benchmark reissued a "buy" rating and set a $160.00 target price on shares of Plexus in a research note on Wednesday. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Plexus has a consensus rating of "Moderate Buy" and an average price target of $155.67.

Get Our Latest Report on Plexus

Institutional Trading of Plexus

A number of large investors have recently made changes to their positions in the company. Inspire Investing LLC lifted its position in Plexus by 4.8% during the 1st quarter. Inspire Investing LLC now owns 2,682 shares of the technology company's stock worth $344,000 after acquiring an additional 123 shares during the period. Strs Ohio acquired a new stake in Plexus during the 1st quarter worth approximately $1,089,000. Acadian Asset Management LLC lifted its position in Plexus by 666.3% during the 1st quarter. Acadian Asset Management LLC now owns 14,660 shares of the technology company's stock worth $1,876,000 after acquiring an additional 12,747 shares during the period. Intech Investment Management LLC lifted its position in Plexus by 34.2% during the 1st quarter. Intech Investment Management LLC now owns 14,823 shares of the technology company's stock worth $1,899,000 after acquiring an additional 3,779 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company's stock valued at $10,197,000 after buying an additional 9,078 shares during the period. 94.45% of the stock is owned by institutional investors and hedge funds.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Recommended Stories

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines